Peter Shrader
Duke University(US)Clinical Research Institute(US)
Publications by Year
Research Areas
Atrial Fibrillation Management and Outcomes, Lipoproteins and Cardiovascular Health, Genetic Associations and Epidemiology, Cardiac Arrhythmias and Treatments, Congenital Heart Disease Studies
Most-Cited Works
- → New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk(2010)2,224 cited
- → Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis(2010)1,790 cited
- → Genotype Score in Addition to Common Risk Factors for Prediction of Type 2 Diabetes(2008)762 cited
- → Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge(2010)635 cited
- → Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes(2016)486 cited
- → Genome-Wide Association Study of Coronary Heart Disease and Its Risk Factors in 8,090 African Americans: The NHLBI CARe Project(2011)316 cited
- → Detailed Physiologic Characterization Reveals Diverse Mechanisms for Novel Genetic Loci Regulating Glucose and Insulin Metabolism in Humans(2010)256 cited
- → Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States(2016)224 cited
- → International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries(2017)213 cited
- → Frequency and Outcomes of Reduced Dose Non–Vitamin K Antagonist Anticoagulants: Results From ORBIT‐AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II)(2018)199 cited